| No | Date | Title | Submitter |
|---|---|---|---|
| 8 | 2025/09/19 | Submission of Audit Report | Prestige BioPharma Limited |
| 7 | 2025/09/16 | [Corrected description]Conclusion of Single Sales Contract or Supply Contract | Prestige BioPharma Limited |
| 6 | 2025/09/11 | Announcement of convocation of general meeting of shareholders | Prestige BioPharma Limited |
| 5 | 2025/09/11 | [Corrected description]Decision on Calling Shareholders' Meeting | Prestige BioPharma Limited |
| 4 | 2025/09/09 | Decision on Calling Shareholders' Meeting | Prestige BioPharma Limited |
| 3 | 2025/08/18 | Conclusion of Single Sales Contract or Supply Contract | Prestige BioPharma Limited |
| 2 | 2025/08/13 | Changes of 30% or More in Sales or Profits/Losses (15% or More in the Case of Large-sized Corporations) | Prestige BioPharma Limited |
| 1 | 2025/07/31 | [Corrected description]Material Business Matters Related to Investment Decisions (특허권 취득) | Prestige BioPharma Limited |